Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:1962-1968
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sayer, J. W.
Right arrow Articles by Timmis, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sayer, J. W.
Right arrow Articles by Timmis, A. D.

Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors

Jeremy W. Sayer, BSc, MB, MRCPa,b, Charles Gutteridge, MD, FRCPatha,b, Denise Syndercombe-Court, PhDa,b, Paul Wilkinson, MB, MRCPa,b and Adam D. Timmis, MD, FRCPa,b

a Department of Cardiology, Royal Hospitals Trust, Environmental Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom
b Department of Haematology, Royal Hospitals Trust, Environmental Epidemiology Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom



View larger version (27K):

[in a new window]
 
Figure 1 Circadian variation of PAI-1 and tPA antigens and activities and the effect of treatment with beta-blocker (bisoprolol) and angiotensin-converting enzyme inhibitor (quinapril). Points represent mean values; figures are the standard deviation for each data point. P1 = placebo; BB = beta-blocker; ACEI = angiotensin-converting enzyme inhibitor.

 


View larger version (18K):

[in a new window]
 
Figure 2 Variation in ß-TG over 24 h and the effect of treatment with beta-blocker (bisoprolol) and angiotensin-converting enzyme inhibitor (quinapril). Points represent mean values; figures are the standard deviation for each data point. P1 = placebo; BB = beta-blocker; ACEI = angiotensin-converting enzyme inhibitor.

 


View larger version (18K):

[in a new window]
 
Figure 3 Twenty-four hour variation of low frequency to high frequency ratio (LF:HF) at baseline (placebo) and after treatment with beta-blocker (bisoprolol) and angiotensin-converting enzyme inhibitor (quinapril). Points represent mean values; figures are the standard deviation for each data point. P1 = placebo; BB = beta-blocker; ACEI = angiotensin-converting enzyme inhibitor.

 


View larger version (18K):

[in a new window]
 
Figure 4 Variation in plasma renin over 24 h and the effect of treatment with beta-blocker (bisoprolol) and angiotensin-converting enzyme inhibitor (quinapril). Points represent mean values; figures are the standard deviation for each data point. P1 = placebo; BB = beta-blocker; ACEI = angiotensin-converting enzyme inhibitor.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement